Search for: "Merck Sharpe and Dohme, Inc." Results 41 - 60 of 91
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2018, 12:57 am by Eszter Szakács
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
22 Jun 2010, 9:36 am
Only yesterday the IPKat reported on Case C-207/10 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
10 Apr 2016, 1:47 am by Mark Summerfield
  However, many cases fall somewhere between these two extremes, with an opposition being only partly successful, and/or the Hearing Officer finding that successful grounds of opposition might nonetheless be overcome by some form of amendment to the patent specification and claims.An example of this last type of outcome is the subject of a recent decision of the Federal Court of Australia in Merck Sharpe & Dohme (Australia) Pty Ltd v Genentech Inc [2016]… [read post]
29 Jun 2010, 6:01 pm by Duncan
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme (IPKat) US: Bio commends Supreme Court for expansive view of patentability in Bilski decision (Patently BIOtech) US: Bilski: Supreme Court refuses to prohibit software, business method, and medical diagnostic method patents (Patent Baristas) US: Supreme Court Certiorari: Summary dispositions of Classen and Prometheus (Patent Baristas) (Patently-O) US: District Court… [read post]
30 Jun 2010, 5:52 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme (IPKat) US: Bio commends Supreme Court for expansive view of patentability in Bilski decision (Patently BIOtech) US: Bilski: Supreme Court refuses to prohibit software, business method, and medical diagnostic method patents (Patent Baristas) US: Supreme Court Certiorari: Summary dispositions of Classen and Prometheus (Patent Baristas) (Patently-O) US: District Court New… [read post]
12 Jan 2011, 5:45 pm by Editors
., Exelon, Fifth Third Bank, Verizon Wireless, Harrah’s Entertainment , Prudential Financial, Inc., Alcatel-Lucent, Axiom, Evonik Degussa Corp., Flex-Time Lawyers, Merck Sharp & Dohme Corp., National Corporate Research, Ltd., and The Vanguard Group Learn more at New Partner and In-House Counsel Conference. [read post]
29 Feb 2016, 11:27 pm
| US trade secrets | Trends in IP Data | EPO's new Chief Economist | GIFs and copyright | Katcall for new positions in the IPKat team | Star Wars IP.Never too late 83 [week ending on Sunday 31 January] – The AmeriKat from the Silicon Valley | INGRES conference on developments in European IP law 2015 - patents | Economics of UK creative industries |Stretchline v H&M | Merck KGaA v Merck Sharp & Dohme |… [read post]
5 Mar 2024, 10:23 am by Dennis Crouch
Sanofi Pasteur and Merck Sharp & Dohme (the “petitioners”) challenged the validity of the ‘559 patent claims in five inter partes review (IPR) proceedings, arguing they were obvious over prior art references disclosing multivalent pneumococcal vaccines. [read post]
29 Jan 2019, 6:32 am by Andrew Hamm
” At The World and Everything in It (podcast), Mary Reichard discusses the oral arguments in Merck Sharp & Dohme Corp. v. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
29 Dec 2011, 11:02 am by Tom Lamb
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. [read post]
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
15 Nov 2020, 6:44 am by Magdaleen Jooste
The judgement was on the case between Merck Sharp & Dohme Limited (“MSD”) and Wyeth LLC’s (“Wyeth”). [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
21 Nov 2012, 5:00 am by Bexis
Merck Sharp & Dohme Corp., 807 N.W.2d 343, 347 (Mich. [read post]
28 Jun 2010, 3:08 am
 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]